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UNIT A2.2Imaging Cavernous Malformations
Cavernous malformations (CMs) represent ∼10% to 15% of vascular malformations.
Their incidence is ∼0.5% at autopsy. They have low pressure, slow flow, and tend to be
angiographically occult (Tomlinson et al., 1994). They are commonly referred to as
cavernous angiomas or cavernomas. CMs consist of enlarged sinusoidal vascular spaces
that have thin walls devoid of smooth muscle and normal endothelium. These form
compact masses within central nervous system (CNS) parenchyma or associated struc-
tures without normal interspersed tissue. The thin walls lack normal endothelium and are
prone to leakage of blood elements. Deposition of blood products in and around CMs
may be extensive (Glendhill et al., 2000).
BASIC
PROTOCOL
CAVERNOUS MALFORMATION
The following sequences comprise our basic protocol for evaluating cavernous malfor-
mations:
1. Three-plane positioning scout.
2. Noncontrast T1-weighted transverse.
3. Transverse gradient echo.
4. Noncontrast coronal proton density (PD)/T2-weighted turbo spin echo.
5. Post contrast T1-weighted transverse.
And an optional:
6. Post contrast T1-weighted transverse with flow compensation.
Although the actual scan time is 12 min and 19 sec (or 15 min and 46 sec with the optional
sequence), because of setup time between sequences and the time necessary to inject the
gadolinium, we tell the patient that this exam will take ∼30 min. Except for the three-plane
positioning scout, if the patient just had a “routine” cranial MR exam, we perform only
those sequences necessary to complete this protocol. Table A2.2.1 lists the necessary
equipment needed to perform the imaging sequences in this unit.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as a crash cart or oxygen.
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Table A2.2.1 Equipment Specifications Needed to Perform the
Following Imaging Sequences
Coil type Circularly polarized head coil
Field strength 1.5 T
Gradient strength Minimum of 15 mT/m (or whatever the
system permits)
Positioning cushion or
head stabilizers
Yes
Knee cushion Yes
Use of contrast agents Yes
Pulse oximeter If patient requires sedation
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Materials
Normal saline (0.9% NaCl)
Sterile extravascular contrast agent (e.g., Magnevist, Omniscan, Prohance)
Set up patient and equipment
1. Interview the patient to assess for contraindications such as cardiac pacemaker,
implanted mechanical devices, and/or ferromagnetic materials. Also, determine if the
patient will need sedation medication, which will necessitate the need for appropriate
monitoring equipment.
Each patient or legal guardian prior to bringing the patient into the exam area signs a
screening form.
The presence of ferromagnetic materials may be a health hazard to the patient while inside
the magnet and/or adversely affect image quality. To determine the safety of scanning such
ferromagnetic materials see Shellock (1996).
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain x-rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Request the patient to change into a gown and remove all personal effects, such as
jewelry, hearing aids, glasses, etc., prior to entering the MRI scan room. All personal
belongings should be secured during the examination.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and artifacts.
5. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected and ask them if they have had questions
answered appropriately.
6. Set up the exam room by securing the circularly polarized (CP)-head coil onto the
table and providing a clean exam table.
7. Escort the patient to the MR examination room and position them according to the
exam to be performed. Review the following items with the patient:
a. Provide earplugs or headphones to the patient to minimize the gradient noise but
assure them that they will still be able to hear you.
b. Provide the patient with a safety squeeze-bulb and demonstrate how it works.
Explain to the patient that they may use the squeeze-bulb if they need assistance
during the exam.
c. Explain to the patient that you will be talking to them between imaging sequences
(i.e., when the loud knocking noise stops).
d. Explain to the patient that it is imperative that they remain motionless during the
loud knocking noise to ensure good results. Also, explain that they should not
reposition their body between imaging sequences.
e The patient may call out at any time if he or she feels it necessary.
f. Provide the patient with an estimate of the examination length. If this entire
protocol will be followed, we suggest that the exam will take approximately half
an hour.
8. Position a support under the patient’s knees to enhance comfort.
9. If the patient is unable to hold still, provide appropriate sedation.
10. Secure the patient’s head with positioning sponges or head stabilizers.
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11. Use the laser light to center on the patient’s nasion.
12. Advance the patient couch to isocenter of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
Sequence 1: Rapid three-plane positioning scout
13. To validate the patient’s position and to have a reference to prescribe successive
imaging sequences, acquire a three-plane orthogonal scout sequence. See Table
A2.2.2 for specific parameters.
Most MR scanners can be programmed to acquire the scout automatically after coil tuning
or after the patient has been placed in isocenter (for systems that do not require tuning).
Siemens acquires the scout in three planes by selecting “various”.
Sequence 2: Noncontrast T1-weighted transverse
14. Run a noncontrast T1-weighted transverse spin echo sequence according to Table
A2.2.3.
On this study we will be looking for multiple round areas of high T1-weighted signal, which
are usually seen in the central portion of these lesions. These deposits often demonstrate
a “popcorn” appearance that is characteristic of many of these lesions.
Sequence 3: Transverse gradient echo
15. Display both the sagittal and transverse scout images in two separate quadrants on
the scan monitor. Change imaging parameters to those listed in Table A2.2.4. Position
slices to the midline of the sagittal scout image. Adjust position of field of view (FOV)
off transverse scout image.
16. Instruct the patient to remain motionless as the scan will begin and last for ∼5 min.
17. Run a transverse gradient echo according to Table A2.2.4.
Table A2.2.2 Imaging Parameters for Sequence 1 (Scout Sequence)
Patient position Supine
Scan type Gradient echo
Imaging planes (orientation) Transverse, sagittal, and coronal
(various)
Central slice or volume center Nasion
Echo time (TE) 6 msec
Repeat time (TR) 15 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 300 mm, 300 mm
Resolution (∆x, ∆y) 1.17 mm, 2.34 mm
Number of data points collected (Nx, Ny) 256, 128
Slice thickness (∆z) 8 mm
Number of slices 3 (one per orientation)
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Not applicable
Saturation pulses Not applicable
Slice series Ascending (caudal to cranial)
Scan time 7 sec
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Table A2.2.3 Imaging Parameters for Sequence 2 (Transverse T1-Weighted Spin
Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices centered to midbrain on sagittal
scout image
Echo time (TE) 15 msec
Repeat time (TR) 560 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4 (rectangular
field of view)
Slice thickness (∆z) 6 mm
Number of slices 20
Slice gap 1.8 mm (−30%)
Number of acquisition (Nacq) 2
Read direction Anterior–posterior
Slice location Vertex to skull base
Saturation pulses None
Slice series Interleaved
Scan time 3 min, 38 sec
Table A2.2.4 Imaging Parameters for Sequence 3 (Transverse Gradient Echo)
Patient position Supine
Scan type 2-D Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices centered to midline on sagittal
scout image
Echo time (TE) 26 msec
Repeat time (TR) 750 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4 (rectangular
field of view)
Slice thickness (∆z) 5 mm
Number of slices 18
Slice gap 1.5 mm (30%)
Number of acquisition (Nacq) 2
Swap read and phase encoding No
Read direction Posterior–anterior
Slice locations Vertex to base of skull
Saturation pulses No
Slice series Interleaved
Scan time 4 min, 50 sec
Supplement 9 Current Protocols in Magnetic Resonance Imaging
A2.2.4
Imaging
Cavernous
Malformations
Gradient echo sequences are the most sensitive sequences for cavernomas. This makes
them the preferred sequence for locating cavernomas in patients who tend to have multiple
lesions. We will be looking for areas of “blooming” where the lesions appear larger and
more indistinct on the gradient echo and T2-weighted spin echo images than on the
T1-weighted spin echo images.
Blooming refers to the increase in signal loss centered on the source that occurs as echo
times get longer. For example, a small black dot from a microhemorrhage would grow or
“bloom” into a larger black region as the echo time increases.
Sequence 4: Noncontrast coronal multiecho
18. Run a noncontrast coronal multiecho scan according to Table A2.2.5.
This is a dual echo turbo spin echo sequence that acquires both proton density weighted
and T2-weighted images simultaneously. On this study, we will be looking for mixed high
signal within the center of the lesions, low signal around their periphery, and progressive
“blooming” with increased T2-weighting between the PD and T2-weighted images. The
proton density weighted images come as a bonus with the T2-weighted images without any
additional expenditure of time and may be useful in this situation.
Figure A2.2.1 is the T2-weighted image from the noncontrast coronal multiecho scan and
beautifully demonstrates the cavernous angioma in the left temporal region.
Sequence 5: Post contrast T1-weighted transverse
Although cavernomas may exhibit enhancement, we will be looking mainly for other
enhancement related lesions such as venous angiomas or hemorrhagic tumors. Some of
these other lesions may not be appreciated on noncontrast examinations.
Table A2.2.5 Imaging Parameters for Sequence 4: Coronal Proton
Density/T2-Weighted Turbo Spin Echo Images
Patient position Supine
Scan type Turbo spin echo (dual)
Imaging plane (orientation) Coronal
Central slice or volume center Slices centered to midbrain on sagittal
scout image
Echo time (TE) 15 msec and 105 msec
Echo train length (ETL) 7
Repeat time (TR) 4500 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4 (rectangular
field of view)
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1.5 mm
Number of acquisition (Nacq) 1
Swap read and phase encoding No
Slice location Equidistant between anterior-posterior
brain
Saturation pulses No
Slice series Interleaved
Scan time 2 min, 3 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
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Figure A2.2.1 Coronal T2-weighted image.
Table A2.2.6 Imaging Parameters for Sequence 5 (Transverse T1-Weighted Spin
Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices centered to midbrain on sagittal
scout image
Echo time (TE) 15 msec
Repeat time (TR) 560 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4 (rectangular
field of view)
Slice thickness (∆z) 6 mm
Number of slices 20
Slice gap 1.8 mm (−30%)
Number of acquisition (Nacq) 2
Read direction Anterior–posterior
Slice location Vertex to skull base
Saturation pulses None
Slice series Interleaved
Scan time 3 min, 38 sec
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19. Remove the patient from the scanner. Do not allow the patient to move on the table.
Establish an intravenous line from which the contrast agent can be injected, and attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm. Move the patient back into the scanner.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion between the scans run before contrast agent injection and those
run after injection.
20. If the patient has moved, run another rapid three-plane positioning pilot scan (see
Sequence 1).
21. Leaving the patient in the magnet, inject the contrast agent, flush the line with 10 ml
saline, and then immediately run a post contrast T1-weighted transverse sequence
according to Table A2.2.6.
A dose of 0.1 mmol/kg of contrast agent is usually given.
Sequence 6: Post contrast T1-weighted with flow compensation (optional)
22. In atypical cases where the diagnosis is still in doubt, if indicated to accentuate flow
within a lesion, run a post contrast T1-weighted sequence with flow compensation
according to Table A2.2.7
COMMENTARY
Background Information
Cavernomas are usually isolated findings but
they may be multiple and familial. They are
relatively rare in the general population, but
when they occur there tend to be multiple lesions
in ∼50% of cases. A familial predilection is seen
where up to 80% of affected family members
have multiple lesions. This is particularly seen
in the Desert Southwest where there is a strong
geographic preponderance for cavernomas. Pa-
Table A2.2.7 Imaging Parameters for Sequence 6 (Transverse T1-Weighted Spin
Echo with Flow Compensation)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices centered to midline on sagittal
scout image
Echo time (TE) 17 msec
Repeat time (TR) 532 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4 (rectangular
field of view)
Slice thickness (∆z) 5 mm
Number of slices 19
Slice gap 1.5 mm (−30%)
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Slice locations Vertex to skull base
Flow compensation Yes
Saturation pulses None
Slice series Interleaved
Scan time 3 min, 27 sec
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tients of Hispanic extraction more commonly
have multiple lesions. Some of these individu-
als have been linked to a genetic mutation on
chromosome seven (Mason et al., 1988).
While cavernomas may occur anywhere in
the CNS, ∼75% are located in the cerebral hemi-
spheres, with 25% in the cerebellum or brain-
stem. When multiple, they may be seen in the
spinal cord. Rarely they may be dural, subdural,
subarachnoid, or intraventricular. Figures
A2.2.2, A2.2.3, and A2.2.4 demonstrate the
classic appearance of a cavernoma in an unusual
intraventricular location.
A 66-year-old female presented with a his-
tory of seizures (Fig. A2.2.2). The scan demon-
strates the classic appearance of a cavernoma in
an unusual intraventricular location.
Figure A2.2.3 shows the T2-weighted image
appearance of the same patient as in the previous
example. This demonstrates the classic appear-
ance of high central signal surrounded by dark
hemosiderin rim.
Figure A2.2.4 shows the unusual intraven-
tricular position of the cavernous angiomas on
T1-weighted imaging of the same patient as in
the two previous examples. While an increasing
number of these lesions are found incidentally
on routine imaging studies, others will still
present with seizures, hemorrhage, focal
neurologic deficit, or headache between the
ages of thirty and sixty.
Of those presenting with symptoms, ∼50%
have had seizures. Frequent occult hemorrhages
make the frequency of intracranial hemorrhage
difficult to access. While the incidence of sub-
clinical hemorrhage is nearly 100%, the rate of
overt hemorrhage leading to clinical symptoms
is ∼0.5% to 2% per year. Approximately 10% to
15% of patients with the disease will develop
clinically significant hemorrhage (Robinson et
al., 1991). The clinical presentation of hemor-
rhage varies according to location with those in
more vital areas such as the brainstem more
likely to be symptomatic. Overt hemorrhage is
more common in females and is prone to occur
during pregnancy.
Grossly the lesions appear multilobulated,
like blue-black mulberries, and are more fre-
quent in frontal and temporal lobes. Microscopi-
cally, the surrounding brain parenchyma is
Figure A2.2.2 Transverse T1-weighted spin echo image. The classic appearance of a cavernoma
in an unusual intraventricular location.
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Figure A2.2.3 T2-weighted transverse image.
Figure A2.2.4 T1-weighted sagittal image without gadolinium.
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Figure A2.2.5 Noncontrast coronal multiecho T2-weighted image.
Figure A2.2.6 T2-weighted sagittal image.
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Figure A2.2.7 T2-weighted transverse image.
Figure A2.2.8 T1-weighted transverse image without gadolinium.
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Figure A2.2.9 T1-weighted transverse image with gadolinium.
Figure A2.2.10 T1-weighted sagittal image without gadolinium.
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gliotic with hemosiderin staining (Fischbein et
al., 2000).
Critical Parameters and
Troubleshooting
Cavernous angiomas often demonstrate sus-
ceptibility artifacts that result from incorrect
frequency encoding. Heterogeneous suscepti-
bility causes a heterogeneous field. This causes
some of the proton’s frequency to be mapped
incorrectly and result in an inappropriate signal
void in the image. A characteristic white band
is often seen at the edge of this void. This is due
to overlapping signals of protons that are inap-
propriately mapped. Imagers are familiar with
this type of artifact around small bits of metal.
Normally we try to minimize susceptibility ar-
tifact by using the highest possible read gradient
(which often corresponds to the shortest possi-
ble TE in some systems) or by using a fast spin
echo technique with the shortest possible spac-
ing (Mitchell, 1999). In this case, we do the
opposite, accentuating the artifact and making
the lesion more conspicuous. Susceptibility ar-
tifact is generally more pronounced with gra-
dient echo techniques. This artifact causes
“blooming” and can be seen to be progressively
more pronounced with gradient echo sequences
and longer TE’s of T2-weighted images.
Figure A2.2.5 is a close up of Figure A2.2.1
and demonstrates indistinctness of the periph-
eral margin of the hemosiderin ring caused by
“blooming.” This tends to accentuate the con-
spicuity of cavernomas with long TE T2-
weighted turbo spin echo and gradient echo
sequences.
This increased sensitivity for cavernomas
makes gradient echo sequence being the se-
quence of choice for finding additional lesions
that may not be appreciated with conventional
imaging techniques. Whereas lesions may be so
characteristic that no other lesions are consid-
ered, occasionally their appearance may be con-
fusing. Extra-axial lesions typically have high
Figure A2.2.11 T2-weighted transverse image.
Current Protocols in Magnetic Resonance Imaging Supplement 5
A2.2.13
Cerebral Venous
Lesions
signal on T2-weighted images, more often en-
hance after gadolinium, and may mimic men-
ingiomas. Intra-axially, classically appearing le-
sions may turn out to represent hemorrhagic
metastasis. In symptomatic patients surgical ex-
cision is recommended if feasible with the role
of radiosurgery being evaluated (Wilson, 1992).
Anticipated Results
These lesions usually have a characteristic
imaging appearance that is related to the pres-
ence of blood products at various evolutionary
stages (Rigamonti et al., 1987). The lesion is
usually round or lobulated with a mixed signal
intensity core.
Figure A2.2.6 shows the T2-weighted image
appearance in a 28-year-old male whose lesion
was found at a routine MRI examination. This
again demonstrates the classic appearance of
high central signal surrounded by a dark he-
mosiderin rim.
There are typically multiple round areas that
are bright on both T1-weighted and T2-weighted
images. These rounded deposits cause many of
these lesions to have a characteristic “popcorn”
appearance. A peripheral ferratin or he-
mosiderin rim varies in thickness and contour.
Sometimes the hemosiderin rim is so pro-
nounced that only a “black hole” is appreciated
on some of the image slices, as is seen on Figure
A2.2.7. The adjacent image demonstrated a
more classic appearance. The patient is a 38-
year-old Hispanic female who experienced
CNS symptoms each time when she went
through one of her pregnancies.
After injection of gadolinium, there may be
partial enhancement and an associated venous
malformation may be demonstrated.
The next noncontrast T1-weighted transverse
image (Fig. A2.2.8) demonstrates the cavernous
angiomas in the right temporal fossa.
The associated venous angioma was not ap-
preciated until the gadolinium enhanced T1-
weighted transverse image (Fig. A2.2.9) was
obtained.
Figure A2.2.10 shows the T1-weighted image
appearance of a 25-year-old female who pre-
sented with brainstem symptoms. This again
demonstrates the classic appearance in what is
not an unusual location.
Figure A2.2.11 shows the T2-weighted image
appearance of the previous 25-year-old female
who presented with brainstem symptoms. The
center of the lesion is high signal on both T1-
and T2-weighted images and there is a dark
hemosiderin rim around the periphery of the
lesion.
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